|Day Low/High||18.03 / 18.47|
|52 Wk Low/High||13.02 / 27.85|
The three either have made recent progress toward advancing products in their pipelines or have caught the eye of analysts.
These are just a few of the names I expect to do well to close out 2018.
These are a few of the names I expect to do well to close out 2018.
Market ends flat to close the trading week even as the S&P 500 closes out its best quarter since 2013. A couple of small biotechs made some stealth moves up this week in including Syndax Pharmaceuticals , which broke through resistance. Also, Therav...
I expect deal volume to have a substantial uptick before the end of 2018 rolls around.
These names are moving up or down in a big way ahead of releasing drug-trial results.
Speculative action is keeping sentiment from being more negative.
The biotech sector has seen a big rally, but there are still opportunities.
2:15 pm update Markets are pretty much where they were 90 minutes ago. The S&P has strengthened a bit and overall equities have held up better than I thought given the potential partial government shutdown this weekend. We will see if stocks hold th...